
Epigral Ltd.
Epigral
₹ 0.00
0.00 (0.00)%
NSE
BSE
Chemicals
Small-cap - With a market cap of ₹51.91 Cr.
| EX-Date | Purpose |
|---|---|
| 26 10 2021 | Quarterly Results |
| 24 01 2022 | Quarterly Results Inter alia, to consider the shifting of registered office of the Company outside the local limits of the town. |
| 25 04 2022 | Audited Results |
| 21 07 2022 | Quarterly Results |
| 20 10 2022 | Quarterly Results |
| 19 01 2023 | Quarterly Results & Interim Dividend |
| 25 04 2023 | Final Dividend & Audited Results |
| 05 08 2023 | Quarterly Results |
| 06 11 2023 | Quarterly Results |
| 24 01 2024 | Quarterly Results |
| 22 04 2024 | Final Dividend & Audited Results |
| 09 11 2024 | Quarterly Results |
| 27 01 2025 | Quarterly Results & Interim Dividend |
| 05 05 2025 | Audited Results & Final Dividend |
| 10 11 2025 | Quarterly Results |
| 30 01 2026 | Quarterly Results |
| 02 05 2026 | Final Dividend & Audited Results |
